Starting to post 5x7 glossy prints of NIH article headlines on my corkboard
(media.greatawakening.win)
You're viewing a single comment thread. View all comments, or full comment thread.
Comments (5)
sorted by:
Reference [9] from the study is at https://www.medrxiv.org/content/10.1101/2021.08.15.21262067v3
It concludes boosters may be warranted, which equals more profits for Big Pharma.
Interestingly:
"Potential conflicts of interest.
S. G. and D. H. C. are recipients of investigator-initiated grants to their universities from Pfizer to study pneumococcal vaccines and Sanofi Pasteur and Seqirus to study influenza vaccines.
S. G. also does consulting for Seqirus, Sanofi, Merck, Vaxart, Novavax, Vaxart, Novavax and Janssen; has served on the speakers bureaus for Seqirus and Sanofi; and reports personal fees from Pfizer and data and safety monitoring board (DSMB) fees from Longevoron.
D. H. C. has done consulting work for Seqirus.
S. D. B. reports royalties from Wolters-Kluwer, lecture fees from Harvard, and DSMB membership for a trial of zoledronic acid in Parkinson patients, outside the submitted work.
C. L. K. reports grants from the Bill & Melinda Gates Foundation, the National Institutes of Health, and Veterans Health Administration, outside the submitted work."
While it may be true...just sayin'.